Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.2700
+0.0530 (24.42%)
Aug 20, 2026, 12:51 PM EST
Guided Therapeutics Revenue
Guided Therapeutics had revenue of $650.00K in the twelve months ending June 30, 2026, up 450.85% year-over-year. In the year 2025, Guided Therapeutics had annual revenue of $767.00K with 10,857.14% growth.
Revenue (ttm)
650.00K
Revenue Growth
+450.85%
P/S Ratio
40.10
Revenue / Employee
216.67K
Employees
3
Market Cap
26.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 767.00K | 760.00K | 10,857.14% |
| Dec 31, 2024 | 7.00K | -91.00K | -92.86% |
| Dec 31, 2023 | 98.00K | 85.00K | 653.85% |
| Dec 31, 2022 | 13.00K | -68.00K | -83.95% |
| Dec 31, 2021 | 81.00K | -21.00K | -20.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 36.88M |
| QHSLab | 3.02M |
| Kelyniam Global | 2.67M |
| PetVivo Holdings | 1.18M |
| Tian'an Technology Group | 734.89K |
| Positron | 444.82K |
| CYduct Diagnostics | 344.78K |
| Vivos | 99.10K |
Guided Therapeutics News
- 4 weeks ago - Guided receives $80,000 payment as fourth installment of purchase order - TheFly
- 5 weeks ago - Guided Therapeutics enters new agreement with Yuanshuo Medical Instruments - TheFly
- 2 months ago - Guided Therapeutics files PMA application clinical report with FDA - TheFly
- 2 months ago - Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA - Business Wire
- 5 months ago - Guided Therapeutics says preliminary analysis of FDA study data completed - TheFly
- 5 months ago - Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering - Business Wire
- 8 months ago - Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva - Business Wire
- 9 months ago - Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor - Business Wire